Study of High Efficient Killing Cell Therapy for Advanced NSCLC

Who May Qualify: - Male or female patients' age from 18 years to 70 years. - Patients who have a expected to live at least 3 months. - pathologically confirmed non-small cell lung cancer. - failed in previous standard chemotherapy and targeted therapy. - Karnofsky performance status 0-1. - your organs (liver, kidneys, etc.) are working well enough based on blood testss. Who Should NOT Join This Trial: - Pregnant and lactating women. - Patients with T cell lymphoma, syphilis, AIDS or combination - Patients with highly allergic or have a history of severe allergies - Patients with severe hepatic or renal dysfunction - Patients with severe autoimmune conditions (where your immune system attacks your own body) or who is being treated with immunosuppressive agents - Patients with severe infection not controlled or High fever - Patients with organ transplantation or waiting for organ transplantation. - Patients with brain metastasis - Patients with severe coagulopathy (e.g. hemophilia) - Patients without adequate ability to understand, sign willing to sign a consent forms and take part in the clinical research voluntarily. Always talk to your doctor about whether this trial is right for you.